Related Experiment Video
Updated: Jun 28, 2026

09:45
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Nanoparticles in photodynamic therapy: an emerging paradigm
Dev Kumar Chatterjee1, Li Shan Fong, Yong Zhang
1Division of Bioengineering, National University of Singapore, 117574, Singapore.
Advanced Drug Delivery Reviews
|October 22, 2008
Summary
Photodynamic therapy (PDT) utilizes photosensitizers, often hydrophobic, requiring delivery systems. A new classification divides nanoparticles into passive carriers and active participants, enhancing PDT efficacy for deeper tissue treatment.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Photochemistry
Background:
- Photodynamic therapy (PDT) is a key cancer treatment, but photosensitizers' hydrophobicity necessitates effective delivery systems.
- Existing classifications for PDT delivery systems focus on surface targeting molecules.
- Recent advancements include nanoparticles with active roles beyond simple carrier functions.
Purpose of the Study:
- To introduce a functional classification for nanoparticles used in photodynamic therapy.
- To distinguish between passive carriers and active participants in photosensitizer excitation.
- To categorize active nanoparticles based on their mechanistic roles in PDT.
Main Methods:
- Proposed a functional classification for nanoparticles in PDT.
- Differentiated nanoparticles into passive carriers and active participants.
- Sub-classified active nanoparticles into photosensitizer nanoparticles, self-illuminating nanoparticles, and upconverting nanoparticles.
Main Results:
- Introduced a novel classification system for PDT nanoparticles.
- Identified active nanoparticles as distinct from non-biodegradable carriers with extraneous functions.
- Highlighted three mechanistic sub-classes of active nanoparticles: photosensitizer, self-illuminating, and upconverting nanoparticles.
Conclusions:
- Active, second-generation PDT nanoparticles offer enhanced therapeutic potential.
- These nanoparticles may overcome limitations of traditional PDT, particularly for deep-seated tumors.
- Further research is needed to address challenges for clinical adoption of these advanced nanoparticles.

